title: Family history of breast cancer: what do women understand and recall about their genetic risk?
abstract: The current study has two aims: (1) to look at people's recall of risk information after genetic counselling and (2) to determine the impact of receiving an audiotape of the genetic consultation on level of recall, cancer related worry, and women's uptake of risk management methods. Using a prospective randomised controlled design, subjects receiving an audiotape were compared with a standard consultation group. Participants were drawn from attenders at the genetic clinics of two London hospitals and included 115 women with a family history of breast cancer. Assessment of perceived genetic risk, mental health, cancer worry, and health behaviour was made before counselling at the clinic (baseline) and by postal follow up. Usefulness of audiotapes and satisfaction with the clinical service was assessed by study specific measures. The data indicate that cancer worry is reduced by provision of an audiotape of the genetic consultation. Recall of the genetic risk figure, however, is not affected by provision of an audiotape and neither is it related to women's overall perception of being more or less at risk of breast cancer than the average woman. Forty-one percent of women accurately recalled their personal risk of breast cancer at one month follow up; however, 25% overestimated, 11% underestimated, and 23% could not remember or did not know their breast cancer risk. Recall of the risk figure is more accurate when the clinical geneticist has given this to the woman as an odds ratio rather than in other formats. Subsequent health behaviour is unaffected by whether women have an audiotape record of their genetic consultation. Results suggest that having a precise risk figure may be less important than women taking away from the consultation an impression that something can be offered to help them manage that risk. Provision of an audiotape of the consultation is of limited usefulness. The need for psychological care to be better integrated into genetic counselling at cancer family clinics was highlighted by the study. The results are discussed in terms of future service development.
authors.affiliation: Royal Marsden NHS Trust and Institute of Cancer Research, Sutton, Surrey, UK.
authors.forename: M
authors.initials: M
authors.lastname: Watson
authors.forename: V
authors.initials: V
authors.lastname: Duvivier
authors.forename: M
authors.initials: M
authors.lastname: Wade Walsh
authors.forename: S
authors.initials: S
authors.lastname: Ashley
authors.forename: J
authors.initials: J
authors.lastname: Davidson
authors.forename: M
authors.initials: M
authors.lastname: Papaikonomou
authors.forename: V
authors.initials: V
authors.lastname: Murday
authors.forename: N
authors.initials: N
authors.lastname: Sacks
authors.forename: R
authors.initials: R
authors.lastname: Eeles
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics* / Q000523:psychology*; D005260:Female; D005817:Genetic Counseling / Q000379:methods*; D020022:Genetic Predisposition to Disease; D006801:Humans; D011939:Mental Recall; D012307:Risk Factors; D013637:Tape Recording